奥兰替尼 | SU 6668 | TSU-68
Orantinib | SU 6668 | TSU-68
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Orantinib | SU 6668 | TSU-68
CAS252916-29-3
FormulaC18H18N2O3
MW310.35
AppearanceYellow to orange powder
Storage conditionStore in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃.
Security information
Product details

Orantinib (NSC 702827) , a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also highly inhibits Flk-1 and FGFR1 trans-phosphorylation. It shows little effect against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2 and does not suppresses EGFR.

Related
(Z)-Orantinib | (Z)-SU6668 | (Z)-TSU-68
History
Ozoralizumab
Solitomab
Quilizumab
Pinatuzumab (Anti-Siglec-2 / CD22)
Enfortumab (Anti-Nectin-4)
Etretinate (Ro 10-9359)
RJR-2403 oxalate | (E)-Metanicotine oxalate
Orantinib | SU 6668 | TSU-68
Adalimumab (anti-TNF-alpha)
Otilimab (Synonyms: GSK 3196165; MOR103)